SGMO·800677106·US·equity·Healthcare - Biotechnology-13D/G
SGMO (SANGAMO THERAPEUTICS INC) is held by 59 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($5M), RENAISSANCE TECHNOLOGIES LLC ($3.5M), TWO SIGMA INVESTMENTS, LP ($2M). Net institutional sentiment: Mixed.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer